Log in to save to my catalogue

Sirolimus and mTOR Inhibitors: A Review of Side Effects and Specific Management in Solid Organ Trans...

Sirolimus and mTOR Inhibitors: A Review of Side Effects and Specific Management in Solid Organ Trans...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_hal_primary_oai_HAL_hal_02136137v1

Sirolimus and mTOR Inhibitors: A Review of Side Effects and Specific Management in Solid Organ Transplantation

About this item

Full title

Sirolimus and mTOR Inhibitors: A Review of Side Effects and Specific Management in Solid Organ Transplantation

Publisher

Cham: Springer International Publishing

Journal title

Drug safety, 2019-07, Vol.42 (7), p.813-825

Language

English

Formats

Publication information

Publisher

Cham: Springer International Publishing

More information

Scope and Contents

Contents

Inhibitors of mechanistic target of rapamycin (mTOR inhibitors) are used as antiproliferative immunosuppressive drugs and have many clinical applications in various drug combinations. Experience in transplantation studies has been gained regarding the side effect profile of these drugs and the potential benefits and limitations compared with other...

Alternative Titles

Full title

Sirolimus and mTOR Inhibitors: A Review of Side Effects and Specific Management in Solid Organ Transplantation

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_hal_primary_oai_HAL_hal_02136137v1

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_hal_primary_oai_HAL_hal_02136137v1

Other Identifiers

ISSN

0114-5916

E-ISSN

1179-1942

DOI

10.1007/s40264-019-00810-9

How to access this item